Literature DB >> 1837422

Blockade of N-methyl-D-aspartate receptors has no effect on certain inspiratory reflexes.

D R Karius1, L M Ling, D F Speck.   

Abstract

Previous studies have indicated that excitatory amino acids are involved in many afferent pathways. This study investigated the effects of intravenous MK-801 [an N-methyl-D-aspartate (NMDA) receptor-associated channel blocker] on several well-known respiratory reflexes elicited by afferent stimulation of the superior laryngeal (SLN), the intercostal (ICN), and the phrenic (PN) nerves. Control responses to stimulation were obtained from recordings of phrenic nerve activity in decerebrate, paralyzed cats. Inspiratory termination elicited by the delivery of stimulus trains to either the SLN or the ICN persisted after MK-801. The onset latency or duration of the short-latency excitations produced by SLN or ICN stimulation were unchanged. The transient inhibitions produced by SLN, ICN, PN, or medullary stimulation showed no significant changes in threshold, onset latency, or duration. Withholding lung inflation produced apneusis after administration of MK-801, indicating a central effect of the drug. Higher doses of MK-801 did not alter the parameters of these reflexes. These data indicate that NMDA-dependent neurotransmission is not required for the production of these reflexes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837422     DOI: 10.1152/ajplung.1991.261.6.L443

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Inspiration-promoting vagal reflex in anaesthetized rabbits after rostral dorsolateral pons lesions.

Authors:  Kazuo Takano; Fusao Kato
Journal:  J Physiol       Date:  2003-06-06       Impact factor: 5.182

2.  Synaptic potentials in respiratory neurones during evoked phase switching after NMDA receptor blockade in the cat.

Authors:  O Pierrefiche; A Haji; A S Foutz; R Takeda; J Champagnat; M Denavit-Saubie
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.